These studies are important in light of the fact that PKC inhibitors are also being researched as therapeutic drugs in diabetes-related hypertension or endothelial insulin resistance [127], that is, disorders where Ca2+ channels are also implicated. This evidence concerns the gene PRRT2 and Hypertension.